Emily Yee is a member of the Lab Ops team where she assists in maintaining operational standards for wet and dry lab spaces while supporting member companies’ needs across both Chicago sites. Throughout her career, Emily continuously strives to serve her community while supporting advancements of research and discovery in medicine. From working in patient care settings to benchwork experiments, her goal is to support the delivery of translational sciences into medical practice. Her past research experience includes assisting in T2D research that aimed to understand the role of lipid protein, perilipin 5, and its mechanisms behind beta cell failure at the University of Iowa. She went on to complete her MS degree at Rush University and focused on orthopedic research by studying histopathological features and markers in hip and spine tissues seen in cam-type FAIS and IVDD. Emily has completed 5 years of active-duty service in the US Navy and currently serves as a Naval reservist.

Haidy Delgado is a lab operations associate at Portal where she helps with day-to-day operations.

Krisha is the Director of Lab and Scientific Operations where she oversees day-to-day operations of the Boston Southline site.

Krisha’s role focuses on being a bridge between the Portal Venture Operations team and member companies by providing the operations support required for member companies to reach their scientific milestones and goals for growth and expansion. She has a track record of setting up labs for startup companies, space planning, and buildouts while managing existing lab and facilities operations.

As part of Portal Innovations operations team, she believes in building highly functional operations team to run at optimum efficiency while allowing scientists to focus on what matters most, bringing new therapies to patients.

Parth Rao is an accomplished pharmaceutical professional with over a decade of experience in the industry. He has a proven track record in managing laboratory operations and facility maintenance for startups and established companies in the life sciences industry. Parth is known for his ability to streamline operations and improve efficiencies, his expertise in managing lab infrastructure, and his strategic vision for achieving growth and success. In this role as the Director of Lab Operations at Portal Innovations, he is responsible for formulating and executing strategic goals, developing operational and capital budgets, and managing relationships with life science startup companies and strategic partners. He will ensure everything will run smoothly and succinctly in our labs at both 400 N Aberdeen and 1375 W Fulton.

Throughout his career, Parth has held various leadership positions within the Biotech and Pharma industries focusing on biologics and novel gene therapies. He earned his Doctor of Pharmacy from the University of Illinois at Chicago and a Master of Science from Northern Illinois University. In his free time, he enjoys hiking, traveling, and spending time with his family

As the Lab Manager at Portal, Elizabeth works closely with Yuan to support daily operations within the lab space and to provide a safe environment for our member companies.  Prior to Portal, Elizabeth was a bench scientist with a particular affinity for analytical chemistry.  In her lab work, she developed a strong understanding and respect for spreadsheets and documentation – her reliability in performance of this understanding (both in quality and consistency) makes her a particularly powerful asset in a safety-focused, scientific environment.

By switching paths from scientist to manager, Elizabeth is able to address the core motivations that had always fueled her pursuit of scientific exploration: to help people. Her starting point contributes to her ability to develop, communicate and teach processes that respond to the actual pain points of scientists.

When not running around the lab or furiously typing on her laptop, Elizabeth enjoys listening to all kinds of podcasts and reading books to unwind.

Dr. Zhang brings a passion for moving science from lab bench to patient bedside, and expertise in immunology and animal models of disease. She most recently cofounded Seurat Therapeutics, a biotech startup spun out of the University of Chicago, focused on developing an intranasal repurposed biologic for treating migraines, seizures, fibromyalgia, and other chronic pain conditions. Dr. Zhang raised $1.5 million and led the company to pre-IND, while managing business development, operations, therapeutic R&D, and strategy.